CAS 92676-86-3
:Cefprozil
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1E)-1-propenyl-, (6R,7R)-
- BMY 28167
- (6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1E)-1-propen-1-yl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1E)-1-propen-1-yl-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propenyl)-, [6R-[3(E),6α,7β(R*)]]-
Cefprozil (E)-isomer
CAS:Cefprozil (E)-isomer is an anticancer agent that has been shown to exhibit potent tumor inhibitory activity. It is an inhibitor of cancer cell growth and proliferation, inducing apoptosis and cell cycle arrest in various human cancer cell lines. Cefprozil (E)-isomer has been found to be effective against a range of cancers, including leukemia and tumors of the urinary system. This compound has been extensively used in traditional Chinese medicine as an anti-cancer agent due to its ability to inhibit protein synthesis in cancer cells. Its mechanism of action involves the inhibition of tumor angiogenesis, which deprives the tumor cells of nutrients required for their growth and survival. Cefprozil (E)-isomer may be a promising candidate for the development of novel anticancer therapies.
Formula:C18H19N3O5SPurezza:Min. 95%Peso molecolare:389.43 g/molRef: ST-EA-CP-C124017
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta

